More on ARTV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/27/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Artiva Biotherapeutics (NQ:ARTV)
Delayed: 9.76 +0.72 (7.96%)
Prev. Close $9.04  
Open$8.89 
52 Wk High$ 
52 Wk Low$ 
Day High$10.12 
Day Low$8.75 
P/E N/A  
EPS$ 
Volume359,781 

Friends, Peers and Foes (?): CTNM (more...)

Jul 17, 2026 07:30 AM Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 14, 2026 07:00 PM Form 4 Artiva Biotherapeutics, For: Jul 10 Filed by: RA Capital Nexus Fund, L.P.
Jun 29, 2026 04:21 PM Form 4 Artiva Biotherapeutics, For: Jun 25 Filed by: RA Capital Nexus Fund, L.P.
Jun 23, 2026 04:05 PM Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun 16, 2026 06:08 PM Form 4 Artiva Biotherapeutics, For: Jun 12 Filed by: RA Capital Nexus Fund, L.P.
Jun 15, 2026 07:37 PM Form SCHEDULE 13D/A Artiva Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 11, 2026 07:36 PM Form 4 Artiva Biotherapeutics, For: Jun 09 Filed by: RA Capital Nexus Fund, L.P.
Jun 8, 2026 06:30 AM Artiva receives FDA RMAT designation for rheumatoid arthritis therapy
Jun 8, 2026 06:30 AM Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today
May 28, 2026 05:14 PM Form SCHEDULE 13D/A Artiva Biotherapeutics, Filed by: GC Corp.
View All Articles

Entities mentioned with ARTV

View All Entities